Live from the NIH registry
Studies recruiting near Greeley right now
Top 25 of 157 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Fort Collins, Colorado (20.2 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Fort Collins, Colorado (20.2 mi)
· Sponsor: TG Therapeutics, Inc.
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Influence of the Gut Microbiome on Blueberry Polyphenol Metabolites
Microbiome Analysis, Metabolomics
N/A
Interventional 125 participants sought
Colorado State University; Food and Nutrition Clinical Research Laboratory; Gifford Building Room 216; 502 West Lake Street, Fort Collins, CO 80523 — Fort Collins, Colorado (20.2 mi)
· Sponsor: Colorado State University
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Longmont United Hospital — Longmont, Colorado (24.5 mi)
· Sponsor: NRG Oncology
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sjögren's Syndrome
Phase 3
Interventional 844 participants sought
Tekton Research, LLC - 2121 E Harmony Rd - PPDS — Fort Collins, Colorado (20.2 mi)
· Sponsor: Amgen
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Banner North Colorado Medical Center — Greeley, Colorado (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: NRG Oncology
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Eye Center of Northern Colorado /ID# 281798 — Fort Collins, Colorado (20.2 mi)
· Sponsor: AbbVie
The Impact of Enhanced Music & Natural Visuals on Emotional Health
Emotion Management Skills, Lifestyle, Healthy
N/A
Interventional 200 participants sought
Colorado State University — Fort Collins, Colorado (20.2 mi)
· Sponsor: soundBrilliance LLC
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
Countermeasures to Circadian Misalignment
Circadian Rhythm Sleep Disorder of Shift Work Type, Metabolic Disease
N/A
Interventional 32 participants sought
Colorado State University — Fort Collins, Colorado (20.2 mi)
· Sponsor: Colorado State University
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Generalized Myasthenia Gravis
Phase 3
Interventional 264 participants sought
Advanced Neurosciences Research LLC — Longmont, Colorado (24.5 mi)
· Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Banner North Colorado Medical Center — Greeley, Colorado (3.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Rocky Mountain Cancer Centers, LLP — Longmont, Colorado (24.5 mi)
· Sponsor: Pfizer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Banner North Colorado Medical Center — Greeley, Colorado (3.3 mi)
· Sponsor: SWOG Cancer Research Network
Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes
Insulin Resistance, Depression
N/A
Interventional 300 participants sought
Colorado State University — Fort Collins, Colorado (20.2 mi)
· Sponsor: Colorado State University
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Orthopaedic and Spine Center of the Rockies — Fort Collins, Colorado (20.2 mi)
· Sponsor: Exactech
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1014 — Fort Collins, Colorado (20.2 mi)
· Sponsor: Immunovant Sciences GmbH
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Neovascular Age-Related Macular Degeneration
Phase 3
Interventional 1,000 participants sought
Eye Center of Northern CO — Fort Collins, Colorado (20.2 mi)
· Sponsor: Hoffmann-La Roche
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastroesophageal-junction Cancer, Monoclonal Antibody
Phase 3
Interventional 550 participants sought
Banner MD Anderson Cancer Center — Greeley, Colorado (3.3 mi)
· Sponsor: Shanghai Henlius Biotech
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
Eye care Center of Northern Colorado doing business as Advanced Vision Research Institute — Longmont, Colorado (24.5 mi)
· Sponsor: Regeneron Pharmaceuticals
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
UCHealth Greeley Hospital — Greeley, Colorado (3.3 mi)
· Sponsor: Canadian Cancer Trials Group